Analytical Data
-
Gene name
AGK
- Application
-
Alternative Names
MULK; Multiple Substrate Lipid Kinase
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q53H12
-
Expression Region
Thr15~Pro300
-
Molecular Weight
62kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Recombinant proteins have gained significant attention in research and biotechnology due to their essential roles in various biological processes and applications. Among these proteins, AGK (Acylglycerol Kinase) has emerged as a focus of study owing to its involvement in lipid metabolism and energy regulation within cells. The AGK gene encodes an enzyme that catalyzes the phosphorylation of monoacylglycerols to diacylglycerols, which are crucial intermediates in lipid signaling pathways. Understanding AGK's structure and function is critical, as it could have implications in metabolic disorders, obesity, and other diseases linked to lipid dysregulation. Recent advancements in recombinant DNA technology have enabled the expression of AGK in various host systems, facilitating the study of its biochemical properties and potential therapeutic applications. The ability to produce AGK in a controlled environment allows researchers to investigate its role in cellular processes and explore its potential as a drug target or biomarker. Moreover, recombinant AGK can be used in high-throughput screening assays to identify novel inhibitors that may regulate its activity, thus contributing to the development of innovative treatments. Overall, the study of recombinant AGK not only enhances our understanding of lipid metabolism but also opens new avenues for therapeutic interventions in related diseases.
